Zymeworks Announces Further Leadership Appointments
- Dr. Jeffrey Smith named Executive Vice President and Chief Healthcare Officer
- Dr. John Fann promoted to Senior VP, Process Sciences
- 7 new Vice Presidents appointed, underscoring motivation to management advancement
/EIN News/ — VANCOUVER, British Columbia, Jan. 04, 2024 (Globe NEWSWIRE) — Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology corporation